ARIEL BRINDLEY: Open Payments
NPI 1508453218 · DOVER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 52 payments from 11 companies in 2025. Trend: 2023 $1,092 · 2024 $1,146 · 2025 $718
Food & beverage: $718
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $204 |
| Alkermes, Inc. | 9 | $139 |
| Lundbeck LLC | 6 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: VRAYLAR, ARISTADA, REXULTI, CAPLYTA, Auvelity, ABILIFY MAINTENA, INVEGA, SPRAVATO.
Industry payments across OH — which companies pay providers there.
